EMA Mulls Dropping Comparative Efficacy Trials For Biosimilars

European Agency Kicks Off Consultation On Whether Such Studies Are Always Necessary

 
• By David Wallace
  
Unnecessary necessary word wooden blocks
Are comparative efficacy studies necessary for all biosimilars? • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products